Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
Microgenics Stress Relief (RF Six Pty Ltd)
Product Name
Microgenics Stress Relief
Sponsor
Date of review outcome
Date of publication
Mar-22
Outcome
Medicine continues to be permitted for supply
Is it safe to continue using this medicine?
Yes
What action should consumers take?
None
Review scope
Targeted (see Additional Information below)
Information reviewed
ARTG Record, Manufacturing Documentation
Issues related to safety
The medicine contains the herbal ingredient rosemary oil which may contain safrole, a potentially harmful substance. There are quantity restrictions in place for safrole to ensure the safe use of listed medicines. The sponsor did not have documentation to support their certification that the medicine complied with safety limits for safrole. Subsequent testing indicated that the quantity of safrole in the medicine is within permissible limits and unlikely to pose a safety risk to consumers.
Issues related to efficacy
The efficacy of the medicine was not assessed as part of this review
Actions taken during the review
The TGA issued an educational letter to the sponsor and the sponsor committed to correcting the issues with the medicine
Additional information
This medicine was targeted to check its compliance in relation to quantity restrictions for the substance safrole